Literature DB >> 15665375

Cost accounting in cost utility analysis of screening and treatment.

Giedrius Vanagas.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15665375      PMCID： PMC1772515          DOI： 10.1136/bjo.2004.050898

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  3 in total

1.  Cost-effectiveness analysis: can we reduce variability in costing methods?

Authors:  Taghreed Adam; Marc A Koopmanschap; David B Evans
Journal:  Int J Technol Assess Health Care       Date:  2003       Impact factor: 2.188

2.  Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants.

Authors:  C Hopley; G Salkeld; J J Wang; P Mitchell
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

3.  Programme costs in the economic evaluation of health interventions.

Authors:  Benjamin Johns; Rob Baltussen; Raymond Hutubessy
Journal:  Cost Eff Resour Alloc       Date:  2003-02-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.